Cancer and blood-related disorders represent a major and growing global health challenge. According to international health authorities, including the World Health Organization, cancers and hematological malignancies such as leukemia, lymphoma, and multiple myeloma account for a significant proportion of global morbidity and mortality. Advances in diagnostics and treatment have improved survival in many cases, but they have also increased the complexity of care, often requiring physicians trained in both oncology and hematology. Onco-hematologists play a critical role in diagnosing, treating, and coordinating long-term care for patients with cancers of the blood, bone marrow, and lymphatic system.
France delivers onco-hematology care within a highly regulated healthcare system that emphasizes patient safety, multidisciplinary decision-making, and adherence to internationally recognized clinical guidelines. Onco-hematologists in France undergo extensive medical education, followed by specialized training in hematology and oncology, and are licensed through nationally regulated pathways. Clinical practice is aligned with European and global standards for cancer diagnosis, chemotherapy, immunotherapy, targeted therapies, and supportive care.
Care is typically provided in tertiary referral hospitals, comprehensive cancer centers, and academic medical institutions. These facilities are equipped with advanced laboratory diagnostics, molecular testing, bone marrow transplantation units, and specialized oncology wards. Treatment planning is individualized and often discussed in multidisciplinary tumor boards, where hematologists, oncologists, pathologists, radiologists, and supportive care teams collaborate to determine appropriate management strategies.
For international patients, France offers a structured healthcare infrastructure characterized by transparent clinical documentation, regulated care pathways, and clearly defined informed consent processes. Emotional and psychological support is increasingly integrated into cancer care, acknowledging the significant mental and emotional burden associated with hematologic and oncologic diagnoses. Overall, onco-hematology services in France are delivered within a system designed to balance scientific rigor, patient-centered communication, and long-term safety.
Professor Olivier Hermine, MD
Specialization: Hematologic malignancies and rare blood disorders
Years of Experience: Over 30 years
His clinical focus includes lymphomas, mastocytosis, and complex hematological diseases, with an emphasis on evidence-based therapies and clinical research integration. He practices at Hôpital Necker-Enfants Malades, a leading academic hospital.
Professor Hervé Dombret, MD
Specialization: Acute leukemias and bone marrow disorders
Years of Experience: Over 30 years
His work focuses on the diagnosis and treatment of acute myeloid leukemia and related conditions, following internationally accepted treatment protocols. He is affiliated with Hôpital Saint-Louis, a nationally recognized center for hematology.
Professor Eric Solary, MD
Specialization: Myelodysplastic syndromes and translational hematology
Years of Experience: Over 25 years
His clinical and research interests include blood cancers and molecular mechanisms of disease progression. He practices at Gustave Roussy Cancer Campus, a comprehensive cancer center.
Professor Marie-Christine Kyrtsonis, MD
Specialization: Multiple myeloma and plasma cell disorders
Years of Experience: Over 20 years
Her clinical focus involves long-term management of plasma cell diseases using standardized European treatment pathways. She works at Hôpital Saint-Antoine, within a multidisciplinary hematology unit.
| Consultation Type | Estimated Cost Range (USD) |
| Initial consultation with a Onco-Hematologist | $150-$450 |
Note: Costs are approximate and provided for general guidance only. Prices vary depending on the healthcare provider, hospital type, city, and consultation format (in-person or remote). Diagnostic tests, imaging, or additional evaluations are not included. Final fees are determined by the provider after an individual clinical assessment and may be affected by currency fluctuations.
Considering cancer or blood disorder care in another country can feel overwhelming and emotionally demanding. Many patients and families seek healthcare systems that emphasize careful evaluation, clear communication, and structured care pathways. France is often considered because of its regulated oncology framework and emphasis on multidisciplinary care.
➤ Availability of English-speaking medical staff and professional medical translators in many facilities
➤ Specialized clinics that manage a high volume of international patients
➤ Government regulations and oversight mechanisms supporting medical tourism safety and international patient protection
➤ Structured hospital documentation, patient-safety protocols, and informed consent practices
For international patients, practical considerations are important to address early. Visa or entry requirements vary by nationality and length of stay and should be confirmed before travel. Cancer treatment may require extended stays, and even initial assessments can involve a recommended stay of 7-14 days depending on diagnostic needs. While English is commonly used in major cancer centers, language barriers may exist outside large urban hospitals. Planning follow-up care after returning home, including coordination with local oncology services, is an essential part of responsible treatment planning.
Patients considering onco-hematology care in France can share their medical reports with Best Clinic Abroad to receive coordinated support, guidance on consultation options, and assistance with organizing the initial stages of care, strictly as a medical travel facilitator.
How many oncologists are there in France?
France has several thousand practicing oncologists and hematology specialists working across public hospitals, private clinics, and academic cancer centers. Exact numbers vary by source and year, but the workforce is considered sufficient to support a national cancer care system with regional and specialized referral centers.
Which country has the best oncology services?
There is no single country that is universally considered the best for oncology services. Countries such as France, Germany, the United States, and the United Kingdom all maintain advanced cancer care systems, but they differ in access, structure, and cost. The most appropriate option depends on your diagnosis, treatment needs, preferences, and ability to coordinate follow-up care.
Disclaimer
“This content is provided for informational purposes only and does not constitute medical advice. Diagnosis and treatment decisions should be made in consultation with a licensed medical specialist based on individual clinical evaluation.”